H-group (homology)
3016.1 C-terminal domain in some PLP-dependent transferases
Ligands and drugs
11,296
Member domains
2,849
with ligand contacts (≤ 4 Å)
25.2% of members
2,535
with DrugDomain annotations
22.4% of members
1,733
with a DrugBank compound
15.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3016.1 belongs to X-group 3016 C-terminal domain in some PLP-dependent transferases, which binds 8.0 ligand superclasses per 20 proteins, broader than 55% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00114 | PLP | Pyridoxal phosphate | 445 |
| DB02824 | PLG | N-Pyridoxyl-Glycine-5-Monophosphate | 134 |
| DB02142 | PMP | Pyridoxamine-5'-Phosphate | 83 |
| DB00145 | GLY | Glycine | 65 |
| DB04299 | MAE | Maleic acid | 46 |
| DB00133 | SER | Serine | 39 |
| DB00151 | CYS | Cysteine | 24 |
| DB04467 | PDA | N-(5'-phosphopyridoxyl)-L-alanine | 24 |
| DB11596 | FFO | Levoleucovorin | 22 |
| DB03345 | BME | Mercaptoethanol | 21 |
| DB08845 | AKG | Oxogluric acid | 19 |
| DB03287 | PPG | 4-(2-Amino-Ethoxy)-2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-but-3-Enoic Acid | 17 |
| DB00142 | — | Glutamic acid | 15 |
| DB03553 | GUA | Glutaric Acid | 14 |
| DB00134 | MET | Methionine | 13 |
| DB02328 | HEN | 2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid | 13 |
| DB03928 | CCO | Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol | 13 |
| DB00120 | PHE | Phenylalanine | 12 |
| DB00139 | SIN | Succinic acid | 12 |
| DB00160 | ALA | Alanine | 12 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| PLP | PYRIDOXAL-5'-PHOSPHATE | 235 |
| CL | CHLORIDE ION | 162 |
| PLG | N-GLYCINE-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YL-METHANE] | 149 |
| NAmetal | SODIUM ION | 88 |
| GLY | GLYCINE | 65 |
| MGmetal | MAGNESIUM ION | 50 |
| MAE | MALEIC ACID | 45 |
| SER | SERINE | 42 |
| PMP | 4'-DEOXY-4'-AMINOPYRIDOXAL-5'-PHOSPHATE | 41 |
| 4LM | (2E)-2-{[(1E)-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene]amino}but-2-enoic acid | 40 |
| FFO | N-[4-({[(6S)-2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid | 39 |
| CAmetal | CALCIUM ION | 37 |
| PLS | [3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YLMETHYL]-SERINE | 27 |
| TVJ | [6-methyl-4-[(~{E})-(oxamoylhydrazinylidene)methyl]-5-oxidanyl-pyridin-3-yl]methyl dihydrogen phosphate | 24 |
| WBJ | (2E)-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)imino]but-3-enoic acid | 23 |
| BME | BETA-MERCAPTOETHANOL | 22 |
| PPG | (2E,3E)-4-(2-aminoethoxy)-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)imino]but-3-enoic acid | 21 |
| 0JO | 2-{[(E)-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene]amino}prop-2-enoic acid | 20 |
| PLR | (5-HYDROXY-4,6-DIMETHYLPYRIDIN-3-YL)METHYL DIHYDROGEN PHOSPHATE | 20 |
| CYS | CYSTEINE | 19 |